Instagram story viewer> @superhuman.network> Posts

Super Human Network

@superhuman.network

21.8K

followers

80

following

The world’s most premium network in longevity and human optimisation. Summit by invitation only.

POSTS STORIES REELS TAGGED

Download All

More than $21 billion has flowed into longevity. Knowing what’s backed by science has never mattered more.

Today Super Human Network and Boston Consulting Group launch The Longevity Review 2026, a new annual benchmark the global longevity field has been missing.

The report examines what research supports, what remains unproven, where capital is flowing, and how people are responding - designed to be an accessible reference point.

It brings together global research and investment data, BCG consumer research across 19 countries, and perspectives from 14 leading experts, including David Sinclair, Andrea Maier, Aubrey de Grey, Dave Asprey and Kayla Barnes-Lentz.

What is the state of longevity 2026?

Download The Longevity Review 2026 to explore where the field stands today and the evidence behind the claims.

Comment “REPORT” and we will DM you the download link. by @superhuman.network

3

206

24 days ago

Super Human was never just an event. It's the connective tissue between science, capital, and the people who can scale breakthroughs into reality.

On June 13, we once again gathered the people rewriting how well and how long humans get to live. The people funding it. The people telling the story to the world.

Together we explored one question: what does it mean to live not just longer, but better?

The ideas exchanged, the connections made, the questions left open - that's exactly what this gathering was built for.

Thank you to everyone who made Super Human Summit 2026 unforgettable.

Filmed and produced by:
@imgnereels
@kimknutshed @mattiasmagnemyr
@ida.rutili by @superhuman.network

3

12

3 months ago

Joe Betts-LaCroix is a longtime tech founder who launched Retro Biosciences with $180 million from Sam Altman and one stated goal: add 10 healthy years to the human lifespan.

These findings come from his conversation with @juliankissa at the latest @superhuman.network summit, and a few of them already have data behind them.

The idea that aging is mechanistic goes back to 1993, when Cynthia Kenyon’s lab showed that changing a single gene, daf-2, doubled the lifespan of the worm C. elegans (Kenyon et al., Nature, 1993). Retro’s first drug candidate, RTR242, builds on another thread from the post.

It’s a pill designed to restart autophagy, the cleanup system brain cells use to clear damaged proteins, and it has started a first-in-human safety trial in Australia with Alzheimer’s as the first target.

The AI point has a paper trail too.

In 2025, OpenAI and Retro reported that a custom model called GPT-4b micro designed new versions of the Yamanaka reprogramming factors that produced around 50 times more stem cell markers in lab-grown cells.

That work was done on cells in a dish, and nothing from it has been tested in people.

Worth being upfront about the timeline.

A safety trial only shows whether a drug is tolerated, and the 2030 approval goal is Retro’s own target, so treat it as ambition until the trials report.

We send a free weekly email covering the latest science on longevity, health, and performance. Comment ‘LAB’ to get on the list.

Educational content only, not medical advice. by @superhuman.network

190

6

4 days ago

What do the experts actually say about the state of longevity?

We interviewed 14 leading voices for The Longevity Review 2026, and their perspectives range from the possibility of whole-body rejuvenation to gaps in today's research.

Dr. David Sinclair believes whole-body rejuvenation could be achievable by 2040. Kayla Barnes-Lentz argues that female longevity needs its own evidence base. Dr. William Kapp sees a missing source of medical data in people who appear healthy.

How far could we go by 2050?

Download The Longevity Review 2026 to explore their views on what’s possible, what remains unanswered, and what needs to change to move the field forward.

Comment “REPORT” and we’ll DM you the download link.

Thank you for being part of the first edition of the Longevity Review:
Dr. David Sinclair
Dr. Eric Verdin
Dr. Nir Barzilai
Dr. Valter Longo
Dr. Tim Spector
Dr. Aubrey de Grey
Joe Betts-LaCroix
Dr. Jamie Justice
Prof. Andrea Maier
Dr. William Kapp
Dr. Jordan Shlain
Dave Asprey
Kayla Barnes-Lentz
Peter Crone by @superhuman.network

3

38

23 days ago

Longevity clinics could completely change what we expect healthcare to do for us.

At Super Human Summit 2026, geriatrician and longevity researcher Dr. Andrea Maier explained why she believes the next generation of these clinics will go far beyond simply giving someone a single biological-age score.

Instead, she says we can increasingly look at the biological age of different parts of the body, including the brain, heart and muscles, and understand why one system may be aging faster or slower than another.

That opens the door to something much more personal.

Rather than walking into a clinic and choosing from a menu of popular interventions, Maier argues that the data should guide what actually makes sense for you.

In her view, the real promise of longevity medicine is being able to understand what is happening inside your body before simply deciding what to do next.

She even says that with the right personalized approach, biological age can sometimes be lowered by several years.

That shift from one-size-fits-all healthcare to care built around how your body is aging is what makes the future of longevity clinics so exciting.

👉 Watch Andrea Maier’s full conversation with @drandreamaier, Matthew Scholz, Todd McAllister and @phildoeslongevity from Super Human Summit 2026. Just comment “watch” and we’ll DM you the link!

🧬 Be sure to follow us @superhuman.network for more breakthroughs shaping the future of longevity and human health. by @superhuman.network

3

15

a month ago

What if the biggest breakthrough in aging comes from changing the code of life itself?

At Super Human Summit 2026 in Stockholm, Matthew Scholz, CEO of Oisín Biotechnologies, shared his view of where longevity could be heading next.

Scholz has spent years working in biotech, and he says the first therapy his team built took about a decade to go from an idea to the vein of a patient.

At the time, there were no approved gene or cell therapies at all. Today, he says, there are several thousand in clinical development.

For Scholz, that progress points toward something much bigger: meaningfully improving healthspan and lifespan may eventually require intervening much deeper in our biology.

He describes it as changing the “code of life,” something that for most of human history was effectively impossible.

Now, advances in gene therapy and synthetic biology are beginning to open possibilities that simply weren’t available before.

It’s a huge idea, and Scholz sums up where he thinks it could lead with one line: “We’ll build things that we can’t understand today.”

👉 Watch Matthew Scholz’s full conversation with @drandreamaier, Todd McAllister and @phildoeslongevity from Super Human Summit 2026. Just comment “watch” and we’ll DM you the link!

🧬 Be sure to follow us @superhuman.network for more breakthroughs shaping the future of longevity and human health. by @superhuman.network

3

4

a month ago

The idea that Alzheimer’s could one day become something we can actually beat still feels almost impossible to say out loud, which is exactly why this work is so exciting.

At Super Human Summit 2026 in Stockholm, Julian Issa sat down with Joe Betts-LaCroix to talk about the scale of the disease and the kind of science Joe’s company, Retro Biosciences, is exploring to push longevity medicine forward.

One of the tools he discusses is Yamanaka factors, a set of proteins that can reset a cell’s identity; used more partially, researchers are studying whether they can push older cells toward a younger state without fully reprogramming them.

Joe says Retro developed new versions of these factors that were about 50X more efficient at reprogramming than the natural versions they tested.

They also saw stronger results in their assays looking at signs of aging reversal, especially from one variant.

None of this means we have a cure for Alzheimer’s today, but it shows how different the search for one could start to look.

If scientists can learn how to safely restore healthier function in aging cells, the implications could reach far beyond a single disease.

👉 Watch Joe Betts-LaCroix‘s and Julian Issa’s conversation from Super Human Summit 2026. Just comment “watch” and we’ll DM you the link!

🧬 Be sure to follow us @superhuman.network for more breakthroughs making the future of medicine feel closer! by @superhuman.network

3

9

a month ago

What happens when a strength machine can make one half of a rep harder than the other?

At Super Human Summit 2026 in Stockholm, we caught up with the @technogym team to see their Biostrength system in action.

One of the features they showed us was Eccentric Overload, which can automatically increase resistance during the return phase instead of keeping the load the same throughout the entire rep.

In this demo, he’s pulling 62 kilograms and then resisting 81 kilograms on the way back.

It’s an interesting approach to getting more out of a movement without simply adding more reps.

The idea is to place more of the challenge where the muscles can handle it, while still keeping the exercise controlled.

The Technogym team also emphasized that strength is only one part of the picture, alongside cardio, mobility and recovery.

It’s a great example of how training equipment is becoming much more personalized to the person using it.

🧬 Be sure to follow us @superhuman.network for more breakthroughs making the future of medicine feel closer! by @superhuman.network

3

2

a month ago

A trillion-dollar longevity company sounds like hype until you look at the size of the problem it would have to solve.

At Super Human Summit 2026, Joe Betts-LaCroix told @juliankissa that Alzheimer’s alone could eventually cost the U.S. around $1 trillion a year if we don’t find much better ways to treat it.

His point wasn’t that longevity is suddenly a gold rush, but that the diseases tied to aging already carry an enormous human and financial burden.

Joe argues that they account for roughly 85% of what we spend medicine on, which puts the scale of the opportunity in a very different light.

The real prize isn’t simply extending the number of years we’re alive, either.

It’s finding ways to give people more years where they’re actually healthy enough to enjoy them.

His team is aiming at an additional 10 years of healthy human lifespan, and breakthroughs anywhere near that scale could reshape far more than the longevity industry.

That’s why Joe believes there may ultimately be room for multiple trillion-dollar companies built around healthier aging.

👉 Watch Joe Betts-LaCroix‘s and Julian Issa’s conversation from Super Human Summit 2026. Just comment “watch” and we’ll DM you the link!

🧬 Be sure to follow us @superhuman.network for more breakthroughs making the future of medicine feel closer! by @superhuman.network

3

7

a month ago

How far can human lifespan actually go?

We caught up with Retro Biosciences founder Joe Betts-LaCroix at Super Human Summit 2026 to talk about where longevity science may be heading next.

Joe points to a simple reason for optimism: researchers are getting better at understanding the mechanisms that drive aging, and more of those mechanisms are starting to look biologically tractable.

When asked whether humans could eventually live to 150, he said he sees no technological reason it should be impossible.

That same confidence came through in his main-stage conversation, where he discussed Retro’s work using AI to design new versions of proteins involved in cellular reprogramming, some of which were roughly 50X more efficient than their natural counterparts. Retro’s larger goal is equally ambitious: add 10 healthy years to human life.

Joe isn’t pretending anyone knows exactly how quickly we’ll get there. His approach stays rooted in data, even while thinking very big about what biology may eventually allow.

And fittingly, he’s already technically enhanced himself a little: there’s a chip implanted in his hand that opens the doors to Retro’s labs.

👉 Watch Joe Betts-LaCroix ‘s conversation from Super Human Summit 2026. Just comment “watch” and we’ll DM you the link!

🧬 Be sure to follow us @superhuman.network for more breakthroughs making the future of medicine feel closer! by @superhuman.network

3

6

a month ago

There’s something fascinating about hearing longevity discussed as both a scientific problem and a massive business opportunity.

At Super Human Summit 2026 in Stockholm, @juliankissa sat down with Joe Betts-LaCroix for a conversation that felt much more grounded than the usual futuristic promises around aging.

Joe kept coming back to the same reality: biology is incredibly hard, most drugs still fail, and better tools only matter if they actually help us understand what works in people.

At the same time, the scale of the opportunity is hard to ignore when diseases tied to aging touch nearly every family eventually.

That’s what makes the trillion-dollar-company conversation feel a lot less far-fetched than it sounds at first.

AI could eventually change how much trial and error is involved in developing new treatments, but Joe is careful not to pretend we’re already there.

He also speaks personally about losing his father to Alzheimer’s and how that made the work feel much more immediate.

It’s a thoughtful look at where longevity stands right now, what still has to be solved, and why so much attention is moving into the space.

👉 Julian and Joe’s conversation from Super Human Summit 2026 is now available to watch. Just comment “watch” and we’ll DM you the link!

🧬 Be sure to follow us @superhuman.network for more breakthroughs making the future of medicine feel closer! by @superhuman.network

3

26

a month ago

Twenty minutes of exercise a week sounds almost laughably low. But Dave Asprey makes a point that’s easy to miss: spending more time working out doesn’t automatically mean getting more from it.

The body doesn’t give extra credit for hanging around the gym—it responds to how hard it was challenged and what happens afterward.

A focused 20-minute session can sometimes do more than an hour of half-effort, although that doesn’t make 20 minutes a magic number for everyone.

Someone training for a marathon, trying to build muscle or simply hoping to stay mobile into their 80s will each need something different.

The balance comes from pushing the body enough to give it a reason to adapt, then allowing it enough time to actually do so.

For longevity, the best routine is probably the one that works well enough to matter and feels realistic enough to keep doing for years.

🧬 Follow us @superhuman.network and learn what can help us live longer and live better!

Source: @dave.asprey on @jayshettypodcast by @superhuman.network

3

0

2 months ago